MdxHealth SA (MDXH)
NASDAQ
Closed
Aug 25, 2026
Day's Range
0.726652 wk Range
0.4000Profile - MDXH - MdxHealth SA
Profile
Mic Code
XNCM
Sector
Healthcare
Industry
Diagnostics & Research
Employees
364
MdxHealth SA is a pioneering biotechnology company specializing in molecular diagnostics. The company's primary function is to improve patient outcomes by offering innovative diagnostic solutions for the early detection of cancer. MdxHealth's non-invasive tests aid in the accurate diagnosis and management of cancers, notably prostate cancer, by providing critical genomic information to healthcare providers. This advancement allows for more informed medical decisions and personalized treatment plans. Operating within the healthcare sector, MdxHealth plays a crucial role in the oncology subfield by facilitating early diagnosis, which is paramount in improving survival rates and treatment efficacy. The company's products are vital for both patients and healthcare professionals looking to leverage precision medicine technologies. Internationally, MdxHealth's tests are seen as significant in reducing the burden of cancer through better diagnostic practices, positioning the company as a key player in the expansion of molecular diagnostics globally.
Profile Details
Type
Common Stock
Address
CAP Business Center
City
Herstal
Zip
4040
Country
Belgium
Phone
866 259 5644
Key Executives - MDXH - MdxHealth SA
Key executives
Cross Listings - MDXH - MdxHealth SA
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
